Literature DB >> 2863872

Negative and deficit symptoms in schizophrenia do respond to neuroleptics.

S C Goldberg.   

Abstract

Five large-scale placebo-controlled studies are cited to show that, contrary to the contention of Johnstone et al. (1976) and Crow (1980), negative and/or deficit symptoms in schizophrenia do indeed respond to neuroleptic treatment. Further evidence is given that it is the "organic-like" symptoms (visual and olfactory hallucinations, disorientation, and memory deficit) that do not respond to neuroleptics. This would more sensibly reformulate the hypothesis of Johnstone et al. (1976) and Crow (1980) to state that schizophrenic patients with enlarged ventricles tend to show symptoms of organicity and tend not to respond to neuroleptics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863872     DOI: 10.1093/schbul/11.3.453

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  11 in total

Review 1.  Some neurobiological aspects of psychotherapy. A review.

Authors:  D Y Liggan; J Kay
Journal:  J Psychother Pract Res       Date:  1999

2.  Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia.

Authors:  Yong Chen; Sookhee Bang; Mary F McMullen; Hala Kazi; Konrad Talbot; Mei-Xuan Ho; Greg Carlson; Steven E Arnold; Wei-Yi Ong; Sangwon F Kim
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

Review 3.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

4.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

Review 5.  Effect of neuroleptics on positive and negative symptoms and the deficit state.

Authors:  J Angst; H H Stassen; B Woggon
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

7.  Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.

Authors:  Mary E Kelley; Gretchen L Haas; Daniel P van Kammen
Journal:  Schizophr Res       Date:  2008-07-11       Impact factor: 4.939

Review 8.  Pharmacological management of schizophrenia in older patients.

Authors:  C Gregory; P McKenna
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 9.  Depression in schizophrenia: current guidelines to treatment.

Authors:  S J Bartels; R E Drake
Journal:  Psychiatr Q       Date:  1989

10.  Affinity of neuroleptics for D1 receptor of human brain striatum.

Authors:  S Kanba; E Suzuki; S Nomura; T Nakaki; G Yagi; M Asai; E Richelson
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.